Likewise, targets of epigenetic silencing identified in IDH1-mutant gliomas, including glycolytic genes [40], retinol binding protein 1 [41], and microRNA miR148a [42], were all associated with reduced cell proliferation and improved survival. The gene discussed is IDH1; the disease is central nervous system cancer.